These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 31090560)
41. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy. Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288 [TBL] [Abstract][Full Text] [Related]
42. Aborted sudden cardiac death: ICD or no ICD. Lachmann V; Makimoto H; Kelm M; Bönner F Clin Res Cardiol; 2017 Sep; 106(9):760-763. PubMed ID: 28396986 [No Abstract] [Full Text] [Related]
43. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study. Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814 [TBL] [Abstract][Full Text] [Related]
44. Ventricular Tachycardia Ablation in Patients With Implantable Cardioverter Defibrillators Should No Longer Be a Therapy of Last Resort. Kanagasundram AN; John RM; Stevenson WG Circulation; 2018 May; 137(18):1885-1887. PubMed ID: 29712693 [No Abstract] [Full Text] [Related]
45. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port. Maagh P; Trappe HJ; Meissner A Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694 [TBL] [Abstract][Full Text] [Related]
46. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing. Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174 [TBL] [Abstract][Full Text] [Related]
47. Psychological and quality-of-life issues in the young patient with an implantable cardioverter-defibrillator. DeMaso DR; Neto LB; Hirshberg J Heart Rhythm; 2009 Jan; 6(1):130-2. PubMed ID: 18774753 [No Abstract] [Full Text] [Related]
48. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population. Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231 [TBL] [Abstract][Full Text] [Related]
57. Impact of shock energy and ventricular rhythm on the success of first shock therapy: the ALTITUDE first shock study. Cha YM; Hayes DL; Asirvatham SJ; Powell BD; Cesario DA; Cao M; Gilliam FR; Jones PW; Jiang S; Saxon LA Heart Rhythm; 2013 May; 10(5):702-8. PubMed ID: 23337541 [TBL] [Abstract][Full Text] [Related]
58. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Sweeney MO Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472 [No Abstract] [Full Text] [Related]
59. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device. Francisco GM; Sharma S; Dougherty AH; Kantharia BK Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529 [TBL] [Abstract][Full Text] [Related]